|
JP2779192B2
(ja)
|
1987-09-17 |
1998-07-23 |
マサチユセツツ・インスチチユート・オブ・テクノロジー |
ヒト赤血球特異的転写エンハンサー
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
AU687117B2
(en)
|
1993-10-25 |
1998-02-19 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5484720A
(en)
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US5952190A
(en)
|
1996-10-04 |
1999-09-14 |
Fanconi Anemia Research Fund, Inc. |
cDNA for fanconi anemia complementation group A
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
WO2001088088A2
(en)
|
2000-05-18 |
2001-11-22 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
HK1048302A1
(zh)
|
1999-08-13 |
2003-03-28 |
大正制药株式会社 |
前列腺素衍生物
|
|
HK1050210B
(en)
|
1999-10-12 |
2007-08-24 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
RU2305708C2
(ru)
|
2001-10-02 |
2007-09-10 |
Энститю Клейтон Де Ля Решерш |
Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
|
|
AU2003223661A1
(en)
|
2002-04-15 |
2003-11-03 |
Rigel Pharmaceuticals, Inc. |
Methods of assaying for cell cycle modulators
|
|
CA2483915A1
(en)
|
2002-05-02 |
2003-11-13 |
University Of Rochester |
Vectors having both isoforms of b-hexosaminidase
|
|
ES2298745T3
(es)
|
2003-04-24 |
2008-05-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Promotores bidireccionales de sintesis y utilizacion de los mismos.
|
|
US20070048285A1
(en)
|
2005-08-24 |
2007-03-01 |
Christopher Baum |
Self-inactivating retroviral vector
|
|
BE1016793A4
(fr)
|
2005-10-04 |
2007-06-05 |
Artelis |
Procede de culture de cellules et dispositif permettant sa mise en oeuvre.
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
WO2008136670A2
(en)
|
2007-05-02 |
2008-11-13 |
Erasmus University Medical Center Rotterdam |
Improved methods and means for lentiviral gene delivery
|
|
EP2333091B1
(en)
|
2007-05-29 |
2017-06-21 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
ES2660180T3
(es)
|
2007-12-07 |
2018-03-21 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
|
DE102008063606A1
(de)
|
2008-12-18 |
2010-06-24 |
Eufets Ag |
Ein-Vektor Tet-System und dessen Verwendung
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
WO2010138750A2
(en)
|
2009-05-27 |
2010-12-02 |
The Salk Institute For Biological Studies |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
|
JP5996429B2
(ja)
|
2009-09-03 |
2016-09-21 |
ジェネンテック， インコーポレイテッド |
関節リウマチの治療、診断及びモニターするための方法
|
|
WO2011043719A1
(en)
|
2009-10-05 |
2011-04-14 |
Ya-Fang Mei |
Replicating viral vectors for gene therapy
|
|
KR20140045411A
(ko)
|
2011-05-16 |
2014-04-16 |
젠자임 코포레이션 |
Ｃｘｃｒ４ 길항제의 용도
|
|
EP2820138B1
(en)
|
2012-02-29 |
2020-10-28 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Retroviral transduction using poloxamers
|
|
AU2013293270B2
(en)
|
2012-07-25 |
2018-08-16 |
Massachusetts Institute Of Technology |
Inducible DNA binding proteins and genome perturbation tools and applications thereof
|
|
EP2931871B1
(en)
|
2012-12-11 |
2026-03-04 |
Pall Technology UK limited |
Recipient for cell cultivation
|
|
EP2840140B2
(en)
|
2012-12-12 |
2023-02-22 |
The Broad Institute, Inc. |
Crispr-Cas based method for mutation of prokaryotic cells
|
|
WO2014100073A2
(en)
|
2012-12-21 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Expression vectors for recombinant protein production in mammalian cells
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
CN104419683A
(zh)
*
|
2013-09-10 |
2015-03-18 |
中国科学院生物物理研究所 |
制备范可尼贫血症患者自体诱导多能干细胞的方法及其应用
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
WO2015073922A2
(en)
|
2013-11-15 |
2015-05-21 |
Northwestern University |
Inhibition of oxidative stress in atrial fibrillation
|
|
US20170037431A1
(en)
|
2014-05-01 |
2017-02-09 |
University Of Washington |
In vivo Gene Engineering with Adenoviral Vectors
|
|
US20170175143A1
(en)
*
|
2014-05-20 |
2017-06-22 |
Regents Of The University Of Minnesota |
Method for editing a genetic sequence
|
|
WO2015188191A1
(en)
|
2014-06-06 |
2015-12-10 |
Wong Wilson W |
Dna recombinase circuits for logical control of gene expression
|
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
WO2016118780A1
(en)
|
2015-01-21 |
2016-07-28 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
MA41506A
(fr)
|
2015-02-13 |
2017-12-19 |
Takeda Vaccines Inc |
Procédés de production de virus pour produire des vaccins
|
|
KR20240119152A
(ko)
|
2015-03-10 |
2024-08-06 |
더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 |
재조합 glut1 아데노-관련 바이러스 벡터 작제물 및 glut1 발현을 회복하기 위한 관련된 방법
|
|
WO2016183593A2
(en)
|
2015-05-14 |
2016-11-17 |
The Regents Of The University Of California |
Prenatal therapy
|
|
SG11201803934YA
(en)
|
2015-11-11 |
2018-06-28 |
Intrexon Corp |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
PT3405215T
(pt)
|
2016-01-19 |
2022-09-20 |
Univ California |
Métodos para o tratamento da doença de danon e outros transtornos da autofagia
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
IL261002B2
(en)
|
2016-02-12 |
2024-07-01 |
Bluebird Bio Inc |
Vcn enhancer compositions and methods of using the same
|
|
CN116144500A
(zh)
|
2016-04-14 |
2023-05-23 |
崔泽尔有限公司 |
具有恒流泵/管道系统的固定床生物反应器
|
|
HUE055862T2
(hu)
*
|
2016-04-20 |
2021-12-28 |
Centro De Investig Energeticas |
Készítmények és eljárások PKLR fokozott génexpressziójára
|
|
CA3058735A1
(en)
|
2016-06-13 |
2017-12-21 |
Bluebird Bio, Inc. |
Gene therapy of neuronal ceroid lipofuscinoses
|
|
WO2017218948A2
(en)
|
2016-06-17 |
2017-12-21 |
Fred Hutchinson Cancer Research Center |
Strategies to assess and/or produce cell populations with predictive engraftment potential
|
|
KR20240151726A
(ko)
|
2016-09-08 |
2024-10-18 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
판코니 빈혈 환자를 위한 유전자 치료
|
|
JP2020500562A
(ja)
|
2016-12-06 |
2020-01-16 |
ブルーバード バイオ， インコーポレイテッド |
ムコ多糖症ｉｉ型のための遺伝子治療
|
|
BR112019011635A2
(pt)
|
2016-12-06 |
2019-11-12 |
Bluebird Bio Inc |
terapia genética para mucopolissacaridose, tipo i
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
WO2018201065A1
(en)
|
2017-04-27 |
2018-11-01 |
Fred Hutchinson Cancer Research Center |
Therapeutic formulations containing cd34+ stem cells derived from negative selection
|
|
SG11202002263TA
(en)
|
2017-10-16 |
2020-04-29 |
Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas |
Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
|
|
WO2019200167A1
(en)
|
2018-04-11 |
2019-10-17 |
Rocket Pharmaceuticals, Ltd. |
Compositions and methods for stem cell transplant
|
|
MX2020011386A
(es)
|
2018-04-27 |
2021-01-29 |
Spacecraft Seven Llc |
Terapia genica para la degeneracion del snc.
|
|
KR102918544B1
(ko)
|
2018-07-12 |
2026-01-27 |
로켓 파마슈티컬스, 리미티드 |
다논병을 치료하기 위한 유전자 요법 벡터
|
|
KR20210046004A
(ko)
|
2018-07-30 |
2021-04-27 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
조혈 세포의 유전자 변형 방법
|
|
BR112021002765A2
(pt)
|
2018-08-16 |
2021-07-20 |
Spacecraft Seven, Llc |
métodos de produção para vetores virais
|
|
BR112021015751A2
(pt)
|
2019-02-12 |
2022-02-08 |
Spacecraft Seven Llc |
Vetores de terapia genética para tratamento da doença de danon
|
|
SG11202112347RA
(en)
|
2019-05-23 |
2021-12-30 |
Spacecraft Seven Llc |
Gene therapy vectors for infantile malignant osteopetrosis
|
|
CA3177341A1
(en)
|
2020-05-20 |
2021-11-25 |
Chester Bittencort SACRAMENTO |
Engineered parkin and uses thereof
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
CN116113700A
(zh)
|
2020-08-05 |
2023-05-12 |
太空飞船七有限责任公司 |
用于glut1表达的腺相关病毒载体及其用途
|
|
KR20230042468A
(ko)
|
2020-08-05 |
2023-03-28 |
스페이스크래프트 세븐, 엘엘씨 |
Csrp3 (시스테인 및 글리신 풍부 단백질 3) 유전자 요법
|
|
KR20230043869A
(ko)
|
2020-08-07 |
2023-03-31 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
|
|
CN116887868A
(zh)
|
2020-12-07 |
2023-10-13 |
太空飞船七有限责任公司 |
达农病的治疗
|
|
JP2024546103A
(ja)
|
2021-12-08 |
2024-12-17 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ａａｖベクターを用いたジャンクトフィリン－２（ｊｐｈ２）遺伝子治療
|
|
EP4444893A4
(en)
|
2021-12-10 |
2026-02-25 |
Spacecraft Seven Llc |
GENE THERAPY FOR TROPONIN C (TNNC1) USING AN AAV VECTOR
|
|
IL314602A
(en)
|
2022-02-08 |
2024-09-01 |
Spacecraft Seven Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
KR20250012749A
(ko)
|
2022-04-22 |
2025-01-24 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 b-세포 림프종 2-관련 안타노겐 3(bag3) 유전자 요법
|